Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

8

Revenue 2017

40

Revenue 2017

Enbrel

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Enbrel was produced by Amgen, Takeda and Pfizer.

Amgen wins Enbrel patent case, knocking back Sandoz's biosimilar plan

Amgen wins Enbrel patent case, knocking back Sandoz's biosimilar plan

The ruling could delay the arrival of biosimilar competition for Enbrel in the US by a decade. ... Enbrel won FDA approval in 1998. Shares in Amgen rose 6% when news of the court ruling emerged.

Amgen CEO says Aimovig is “one of most successful launches”

Amgen CEO says Aimovig is “one of most successful launches” TNF inhibitor Enbrel (etanercept) also fell 5% in the face of competition from newer drugs in indications such as psoriasis.

Amgen’s R&D chief Sean Harper retires to seek biotech post

Amgen’s R&D chief Sean Harper retires to seek biotech post 1bn – around $400m ahead of forecasts – with newer products helping to offset an 11% decline in Amgen’s top-seller Enbrel (etanercept) to $1.3bn, affected by competition for TNF inhibitors

Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS

Daily Brief: Tagrisso's first line approval, EULAR and EHA, and why Stephen Hawking was wrong on NHS III candidate upadacitinib - analysts predict these drugs will seize share from older drugs such as Amgen/Pfizer’s Enbrel.

Sun Pharma passes milestone with novel psoriasis drug approval

Sun Pharma passes milestone with novel psoriasis drug approval inhibitor Enbrel (etanercept), a widely-used biologic for the skin condition. ... For years treatment for patients requiring systemic therapy has been dominated by TNF blockers such as Enbrel and AbbVie’s Humira (adalimumab), but these are now expected

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics